Tabla de contenido
Idiomas disponibles
Idiomas disponibles
ES
FR
EN
CoxaFlex®
DE
of these intervals has to be defined
individually for each patient.
• Should the product have been
subject to disproportionate stress,
it must be checked for potential
damage by an orthopedic technician
before further use.
• Harmful pressure caused by the orthosis
may cause skin injuries or disrupt blood
flow and must be avoided.
•
This product is intended for use on
one person. It may not be reused
on another person.
EN-4
User Manual
Intended Product Use
CoxaFlex® was developed in order to
treat hip dysplasia and luxation more
effetively and more safely. It helps
control the growth of the cartilaginous
and bony articulation partners, and
specifically supports the ideal shaping
of the hip joint.
CoxaFlex® resulted from the close co-
operation of physicians and technicians
and will foster the subsequent deve-
lopment of the hip joint when applied
correctly.
As with many disorders, the prospects
of a complete recovery of the dysplastic
hip will improve if the defect is detected
and treated early on.
When treated within the first days and
weeks of life, regular dysplasia can
usually be healed within a few weeks.
Dysplasia stemming from a preceding
luxation, however, usually takes several
months of orthotic treatment to heal.
Constant and regular control exami-
nations (at first every 2 to 3 days) are
as much part of a good treatment plan
as a professionally fitted and correctly
applied orthosis. Therefore, the close
cooperation of physicians, technicians
and parents is indispensable for the
patient's healthy future.
Newborns and infants show a high
degree of strong, reflexive, pedalling
leg movements. Thus, children subcon-
sciously reject any form of restriction
to their mobility, and might show some
Tabla de contenido
